Determinants of adherence to delayed-release doxylamine and pyridoxine in patients with nausea and vomiting of pregnancy

Therapeutic Drug Monitoring

Volumn 34, Issue 5, 2012, Pages 569-573

  Costantine, Maged M ^a   Matok, Ilan ^b   Chiossi, Guisseppe ^a   Clark, Shannon ^a   Miodovnik, Menachem ^c   Umans, Jason G ^c   Caritis, Steve ^d   Hankins, Gary D V ^a   Koren, Gideon ^b,e  

^a University of Texas Medical Branch School of Medicine   (United States)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

adherence; doxylamine; nausea and vomiting of pregnancy; pyridoxine

Indexed keywords

BENDECTIN; DOXYLAMINE PLUS PYRIDOXINE;

ADULT; ARTICLE; CONTROLLED STUDY; DELAYED RELEASE FORMULATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; ETHNICITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NAUSEA AND VOMITING; NAUSEA AND VOMITING OF PREGNANCY; PATIENT COMPLIANCE; PREDICTION; PREGNANCY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ADULT; ANTIEMETICS; COHORT STUDIES; DELAYED-ACTION PREPARATIONS; DOUBLE-BLIND METHOD; DOXYLAMINE; DRUG COMBINATIONS; FEMALE; HUMANS; MEDICATION ADHERENCE; NAUSEA; PREGNANCY; PREGNANCY COMPLICATIONS; PYRIDOXINE; VOMITING;

EID: 84866548310     PISSN: 01634356     EISSN: 15363694     Source Type: Journal    
DOI: 10.1097/FTD.0b013e31826e7997     Document Type: Article

References (29)

1. American College of Obstetricians and Gynecologists. Nausea and vomiting of pregnancy. ACOG Practice Bulletin No. 52. Obstet Gynecol. 2004;103:803-816.
2. Piwko C, Ungar WJ, Einarson TR, et al. The weekly cost of nausea and vomiting of pregnancy for women calling the Toronto Motherisk Program. Curr Med Res Opin. 2007;23:833-840.
3. Niebyl Jr. Clinical practice. Nausea and vomiting in pregnancy. N Engl J Med. 2010;363:1544-1550.
4. Koren G, Pastuszak A, Ito S. Drugs in pregnancy. N Engl J Med. 1998; 338:1128-1137.
5. Brent R. Medical, social, and legal implications of treating nausea and vomiting of pregnancy. Am J Obstset Gynecol. 2002;186:S262-S266.
6. Kutcher JS, Engle A, Firth J, et al. Bendectin and birth defects, II: ecological analyses. Birth Defects Res A Clin Mol Teratol. 2003;67:79-87.
7. McKeigue PM, Lamm SH, Linn S, et al. Bendectin and birth defects, I: a metaanalysis of the epidemiologic studies. Teratology. 1994;50:27-37.
8. Koren G, Clark S, Hankins GD, et al. Effectiveness of delayed-release doxylamine and pyridoxine for nausea and vomiting of pregnancy: a randomized placebo controlled trial. Am J Obstet Gynecol. 2010;203:571.e1.
9. Koren G, Boskovic R, Hard M, et al. Motherisk-PUQE (pregnancy-unique quantification of emesis and nausea) scoring system for nausea and vomiting of pregnancy. Am J Obstet Gynecol. 2002;186: S228-S231.
10. Koren G, Piwko C, Ahn E, et al. Validation studies of the pregnancy unique-quantification of emesis (PUQE) scores. J Obstet Gynaecol. 2005;25:241-244.
11. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005; 353:487-497.
12. Contreras-Yáñez I, Ponce De León S, Cabiedes J, et al. Inadequate therapy behavior is associated to disease flares in patients with rheumatoid arthritis who have achieved remission with disease-modifying anti-rheumatic drugs. Am J Med Sci. 2010;340:282-290.
13. McDonnell PJ, Jacobs MR. Hospital admissions resulting from preventable adverse drug reactions. Ann Pharmacother. 2002;36:1331-1336.
14. Senst BL, Achusim LE, Genest RP, et al. Practical approach to determining costs and frequency of adverse drug events in a health care network. Am J Health Syst Pharm. 2001;58:1126-1132.
15. Berg JS, Dischler J, Wagner DJ, et al. Medication compliance: a healthcare problem. Ann Pharmacother. 1993;27:S1-S24.
16. Souza AI, Batista Filho M, Bresani CC, et al. Adherence and side effects of three ferrous sulfate treatment regimens on anemic pregnant women in clinical trials. Cad Saude Publica. 2009;25:1225-1233.
17. Shatrugna V, Raman L, Kailash U, et al. Effect of dose and formulation on iron tolerance in pregnancy. Natl Med J India. 1999;12:18-20.
18. Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001;23:1296-1310.
19. Grierson J, Koelmeyer R, Smith A, et al. Adherence to antiretroviral therapy: factors independently associated with reported difficulty taking antiretroviral therapy in a national sample of HIV-positive Australians. HIV Med. 2011;12:562-569.
20. Gamble J, Stevenson M, Heaney LG. A study of a multi-level intervention to improve non-adherence in difficult to control asthma. Respir Med. 2011;105:1308-1315.
21. Garcia Popa-Lisseanu MG, Greisinger A, Richardson M, et al. Determinants of treatment adherence in ethnically diverse, economically dis-advantaged patients with rheumatic disease. J Rheumatol. 2005;32:913-919.
22. Stern A, Sánchez-Magro I, Rull M. Chronic noncancer pain intensity is inversely related to analgesic adherence in pain clinics. J Med Econ. 2011;14:568-575.
23. Graziottin A, Gardner-Nix J, Stumpf M, et al. Opioids: how to improve compliance and adherence. Pain Pract. 2011;11:574-581.
24. Cramer J, Rosenheck R, Kirk G, et al. Medication compliance feedback and monitoring in a clinical trial: predictors and outcomes. Value Health. 2003;6:566-573.
25. Sajatovic M, Velligan DI, Weiden PJ, et al. Measurement of psychiatric treatment adherence. J Psychosom Res. 2010;69:591-599.
26. Walsh JC, Mandalia S, Gazzard BG. Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome. AIDS. 2002;16:269-277.
27. Rudd P, Byyny RL, Zachary V, et al. Pill count measures of compliance in a drug trial: variability and suitability. Am J Hypertens. 1988;1:309-312.
28. Pullar T, Kumar S, Tindall H, et al. Time to stop counting the tablets? Clin Pharmacol Ther. 1989;46:163-168.
29. Cramer JA, Mattson RH, Prevey ML, et al. How often is medication taken as prescribed? A novel assessment technique. JAMA. 1989;261:3273-3277.